Business Description
Poly Medicure Ltd
ISIN : INE205C01021
Total Employee Number:
3,082Compare
Compare
Traded in other countries / regions
531768.India Index Membership
NIFTY 500 IPO Date
2011-12-07Description
Poly Medicure Ltd engages in the manufacturing and sale of medical devices. It offers disposable medical devices for infusion therapy, blood management, gastroenterology, vascular access, surgery and wound drainage, anesthesia, and urology. Some of its products include Ventilator Circuit Combo Kits, Bain Circuits, Safety Introducer Needles, High-Pressure Vaccum Bottle-Triplet, Catheters, and others. Geographically, it derives a majority of its revenue from exports. The company operates under one segment namely Medical Devices.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 2.47 | |||||
Equity-to-Asset | 0.79 | |||||
Debt-to-Equity | 0.11 | |||||
Debt-to-EBITDA | 0.63 | |||||
Interest Coverage | 9.32 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 14.56 | |||||
Beneish M-Score | -0.26 | |||||
WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 15.9 | |||||
3-Year EBITDA Growth Rate | 19.4 | |||||
3-Year EPS without NRI Growth Rate | 19.3 | |||||
3-Year FCF Growth Rate | -5.8 | |||||
3-Year Book Growth Rate | 33.3 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 22.67 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 17.9 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 32.05 | |||||
9-Day RSI | 42.85 | |||||
14-Day RSI | 48.53 | |||||
3-1 Month Momentum % | 10.89 | |||||
6-1 Month Momentum % | 3.77 | |||||
12-1 Month Momentum % | -20.87 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 3.37 | |||||
Quick Ratio | 2.62 | |||||
Cash Ratio | 1.52 | |||||
Days Inventory | 172.1 | |||||
Days Sales Outstanding | 84.78 | |||||
Days Payable | 52.62 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 0.21 | |||||
Dividend Payout Ratio | 0.11 | |||||
3-Year Dividend Growth Rate | 11.9 | |||||
Forward Dividend Yield % | 0.21 | |||||
5-Year Yield-on-Cost % | 0.21 | |||||
3-Year Average Share Buyback Ratio | -1.8 | |||||
Shareholder Yield % | -0.53 |
Profitability Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 59.81 | |||||
Operating Margin % | 9.09 | |||||
Net Margin % | 17.11 | |||||
EBITDA Margin % | 29.91 | |||||
FCF Margin % | -3.31 | |||||
OCF Margin % | 13.14 | |||||
ROE % | 10.95 | |||||
ROA % | 9 | |||||
ROIC % | 5.39 | |||||
3-Year ROIIC % | 5.07 | |||||
ROC (Joel Greenblatt) % | 23.69 | |||||
ROCE % | 14.46 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 51.34 | |||||
Forward PE Ratio | 41.39 | |||||
PE Ratio without NRI | 50.56 | |||||
Shiller PE Ratio | 79.13 | |||||
Price-to-Owner-Earnings | 96.43 | |||||
PEG Ratio | 2.66 | |||||
PS Ratio | 8.77 | |||||
PB Ratio | 5.32 | |||||
Price-to-Tangible-Book | 6.2 | |||||
Price-to-Operating-Cash-Flow | 69.04 | |||||
EV-to-EBIT | 36.02 | |||||
EV-to-EBITDA | 28.63 | |||||
EV-to-Revenue | 8.56 | |||||
EV-to-FCF | -266.98 | |||||
Price-to-GF-Value | 0.7 | |||||
Price-to-Projected-FCF | 8.3 | |||||
Price-to-DCF (Earnings Based) | 2.12 | |||||
Price-to-Peter-Lynch-Fair-Value | 2.26 | |||||
Price-to-Graham-Number | 3.73 | |||||
| Price-to-Net-Current-Asset-Value | 14.63 | |||||
| Price-to-Net-Cash | 274.92 | |||||
Earnings Yield (Greenblatt) % | 2.77 | |||||
FCF Yield % | -0.38 | |||||
Forward Rate of Return (Yacktman) % | 18.82 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Poly Medicure Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 18,752.592 | ||
| EPS (TTM) (₹) | 31.75 | ||
| Beta | 0.8969 | ||
| 3-Year Sharpe Ratio | 0.34 | ||
| 3-Year Sortino Ratio | 0.6 | ||
| Volatility % | 50.44 | ||
| 14-Day RSI | 48.53 | ||
| 14-Day ATR (₹) | 56.885191 | ||
| 20-Day SMA (₹) | 1675.435 | ||
| 12-1 Month Momentum % | -20.87 | ||
| 52-Week Range (₹) | 1182 - 2144.9 | ||
| Shares Outstanding (Mil) | 101.36 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Poly Medicure Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Poly Medicure Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| Second quarter earnings conference call for 2027 | 2026-11-10 17:30 | In 110 days | ||
| Second quarter earnings results for 2027 | 2026-11-10 | In 109 days | ||
| General meeting for 2026 | 2026-09-25 10:00 | In 64 days | ||
| Annual report for 2026 | 2026-09-03 | In 41 days | ||
| First quarter earnings conference call for 2027 | 2026-08-07 16:00 | In 15 days | ||
| First quarter earnings results for 2027 | 2026-08-07 | In 14 days | ||
| Fourth quarter earnings conference call for 2026 | 2026-05-25 17:00 | 1,598.20 (+2.77%) | ||
| Fourth quarter earnings results for 2026 | 2026-05-25 | 1,598.20 (+2.77%) | ||
| Third quarter earnings conference call for 2026 | 2026-02-06 16:00 | 1,502.50 (-1.15%) | ||
| Third quarter earnings results for 2026 | 2026-02-06 | 1,502.50 (-1.15%) |
Show
Entries
Poly Medicure Ltd Frequently Asked Questions
What is Poly Medicure Ltd(NSE:POLYMED)'s stock price today?
The current price of NSE:POLYMED is ₹1630.30. The 52 week high of NSE:POLYMED is ₹2144.90 and 52 week low is ₹1182.00.
When is next earnings date of Poly Medicure Ltd(NSE:POLYMED)?
The next earnings date of Poly Medicure Ltd(NSE:POLYMED) is 2026-08-07 Est..
Does Poly Medicure Ltd(NSE:POLYMED) pay dividends? If so, how much?
The Dividend Yield %  of Poly Medicure Ltd(NSE:POLYMED) is 0.21% (As of Today), Highest Dividend Payout Ratio of Poly Medicure Ltd(NSE:POLYMED) was 0.37. The lowest was 0.06. And the median was 0.13. The  Forward Dividend Yield % of Poly Medicure Ltd(NSE:POLYMED) is 0.21%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Poly Medicure Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers